Pharmaceutical Drug Development Annual Review 2025
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
This report investigates the year 2025 in the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the industry via regulatory, clinical, and market-based analysis, allowing you to discern the large-scale changes and how best to pivot to prioritize them within your sector.
Scope
This 50-page report gives important, expert insight you won’t find in any other source. 28 figures and tables throughout the report illustrate major points and trends in future pharmaceutical sales forecasts and company pipelines. This report is required reading for:
Investors that want to understand past trends impacting the biopharmaceutical industry as well as identifying companies to invest in
Companies that are interested in entering the biopharmaceutical space and where best to focus on
Large pharma companies with investment groups or BD teams looking to see which companies lead the industry in the past and how they led
Small and medium pharma who want to focus their drug portfolio on future trends and are looking for partnership opportunities
Reasons to Buy
Insights on how drug development in 2025 may impact future approvals
Insights on how drug approvals in 2025 may impact future drug development and approval trends
Sales and regulatory-based insights into 2025 covering various drugs and companies
Bristol-Myers Squibb Co
AstraZeneca Plc
Novartis AG
F. Hoffmann-La Roche Ltd
Merck & Co Inc
Johnson & Johnson
Sanofi
Pfizer Inc
AbbVie Inc
Eli Lilly and Co
Eisai Co Ltd
Anavex Life Sciences Corp
Vertex Pharmaceuticals Inc
Madrigal Pharmaceuticals Inc
Astellas Pharma Inc
Bayer AG
Biogen Inc
Mitsubishi Tanabe Pharma Corp
Takeda Pharmaceutical Co Ltd
UCB SA
Amgen Inc
Novo Nordisk AS
Lee's Pharmaceutical Holdings Ltd
Jiangsu Hengrui Medicine Co Ltd
Ipsen SA
Daiichi Sankyo
Regeneron
Vanda Pharma ,Basilea Pharma
Dachii Sankyo
Merck & Co
Table of Contents
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more Pharmaceuticals reports